Silence Therapeutics (SLN) Gross Profit (2024 - 2026)
Silence Therapeutics (SLN) posted Gross Profit of $411000.0 for Q1 2026, up 1768.18% sequentially from $22000.0 in Q4 2025, and up 367.05% YoY from $88000.0 in Q1 2025.
Silence Therapeutics (SLN) Gross Profit (2024 - 2026) Analysis & Trends
Silence Therapeutics has reported Gross Profit for 3 years, with the latest figure at $411000.0 in Q1 2026.
- Quarterly Gross Profit rose 367.05% year-over-year to $411000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $667000.0 (down 96.42% YoY) and the FY2025 annual result came in at $344000.0, down 98.91% from the prior year.
- Gross Profit advanced to $411000.0 in Q1 2026 per SLN's latest filing, from $22000.0 in the prior quarter.
- Over five years, Gross Profit peaked at $23.3 million in Q4 2024 and troughed at -$2.6 million in Q2 2024.
- A 3-year average of $3.6 million and a median of $95000.0 in 2025 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2025 and 2026: Gross Profit sank 99.91% in 2025, then soared 367.05% in 2026.
- Over 3 years, Gross Profit stood at $23.3 million in 2024, then tumbled by 99.91% to $22000.0 in 2025, then surged by 1768.18% to $411000.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $411000.0, $22000.0, and $95000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Silence Therapeutics | 648.22 Mn | 576.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 411,000.00 |
| Mar 31, 2026 | 411,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 95,000.00 |
| Sep 30, 2025 | 95,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Mar 31, 2025 | 88,000.00 |
| Dec 31, 2024 | 23.27 Mn |
| Dec 31, 2024 | 23.27 Mn |
| Sep 30, 2024 | -2.14 Mn |
| Sep 30, 2024 | -2.14 Mn |
| Jun 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -2.58 Mn |
| Mar 31, 2024 | 12.90 Mn |
| Mar 31, 2024 | 12.90 Mn |